Insider Trading & Ownership - Vignola Mark J.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vignola Mark J.
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-01-02
Sale		 2025-01-06
7:30 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 17,188 $5.7612 $99,024 74,752
(Direct)		 View
2024-09-10
Sale		 2024-09-12
6:10 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 10,000 $11 $110,000 146,940
(Direct)		 View
2024-05-31
Purchase		 2024-06-04
6:05 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 4,791 $4.44 $21,272 91,940
(Direct)		 View
2023-11-30
Purchase		 2023-12-04
6:03 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 743 $3.78 $2,809 18,399
(Direct)		 View
2023-05-31
Purchase		 2023-06-02
5:03 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 9,997 $1.41 $14,096 17,656
(Direct)		 View
2022-11-30
Purchase		 2023-02-03
6:01 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 3 $1.41 $4 367,659
(Direct)		 View
2022-05-31
Purchase		 2022-06-08
9:27 pm		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 7,656 $1.47 $11,254 7,656
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-09-10
Exercise		 2024-09-12
6:10 pm		 N/A
2032-01-25		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 10,000 $0 146,940
(Direct)		 View
2024-09-10
Exercise		 2024-09-12
6:10 pm		 N/A
N/A		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 10,000 $5.36 146,940
(Direct)		 View
2024-01-23
Option Award		 2024-01-25
7:17 pm		 N/A
2034-01-22		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 206,250 $0 224,649
(Direct)		 View
2023-02-01
Option Award		 2023-02-03
6:01 pm		 N/A
2033-01-31		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 360,000 $0 367,659
(Direct)		 View
2022-01-26
Option Award		 2022-01-28
9:02 pm		 N/A
2032-01-26		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 65,000 $0 65,000
(Direct)		 View
2021-09-28
Option Award		 2021-09-30
9:17 pm		 N/A
2031-09-28		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 120,000 $0 120,000
(Direct)		 View

Ownership		 2021-02-04
5:14 pm		 N/A
2030-09-09		 Terns Pharmaceuticals Inc. TERN Vignola Mark J.
Chief Financial Officer		 0 $0 227,807
(Direct)		 View